This is early beta for now! Can't handle all templates properly
Hankkija
| Vastaanotettu Hilmaan | 2023-10-03 |
| Ilmoituksen numero | 2023-137761 |
| TED numero | 2023/S 193-603625 |
| Ostajaorganisaatio | Ministry of Social Affairs and Health (0244685-8 ) P.O. BOX 33 FI-00023 Helsinki https://stm.fi/en/frontpage |
| Hankinnan otsikkotiedot | Meningococcal Group B Vaccine 2024-2025 (2026, 2027) |
| Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio | |
| Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen | 300 000 EUR |
| Alkuperäinen ilmoitus | https://www.hankintailmoitukset.fi/en/public/procurement/85557/notice/137761/overview |
| Originaali JSON tietue | 137761.json |
Ostettava
| Hankinnan lyhyt kuvaus | The purpose of STM and the Customer was to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for adults, children and infants. More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/meningococcal-vaccines/meningococcus-b-vaccine The Customer will implement the procurement on behalf of STM. |
| Hankintanimikkeistö (CPV) pää | Vaccines (33651600) |
| Hankintanimikkeistö (CPV) muut | Pharmaceutical products (33600000) General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000) |
| Aluekoodi | FI |
| Pääasiallinen suorituspaikka |
Sopimukset
| Päätös päivämäärä | 2023-08-29 |
| Sopimusnumero | 1 |
| Myyjät | GlaxoSmithKline Oy (FI), 0108378-4 |
